Searched for
VINEETA BAL
Covishield immune responses against Covid variants higher than Covaxin: StudyThe yet-to-be peer-reviewed study, posted on the preprint server MedRxiv on Friday, also found that when compared to pre-vaccination baseli...- Fourth Covid vaccine dose unwarranted right now but increased surveillance needed: ExpertsA fourth shot of a Covid preventive is unwarranted at the moment as most people in the country are yet to receive a third dose and there is...
- China launches a COVID-19 vaccine inhaled through the mouthThe vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated individuals,...
- Easy to use, effective & economical: Nasal Covid vaccines to be a game-changer, say scientistsResearchers believe mucosal vaccines may prevent even mild cases of illness and block transmission to other people.
- Easy to use, more effective and cheap, nasal Covid vaccines can be game changer: scientistsEarlier this month, Bharat Biotech announced that its iNCOVACC (BBV154),the world's first intranasal COVID-19 vaccine, has received approva...
- Covid vaccines not linked to 'sudden adult death syndrome', say scientists"There appears to be no evidence whatsoever so far linking COVID-19 vaccines and such deaths," immunologist Satyajit Rath from Pune's India...
- Covid boosters leading to positive HIV test? Experts debunk claim"I don't see why would a booster lead to a positive HIV test. We should not be carried away by misinformation and information that are not ...
- Double vaccinate against Covid first, experts say amid calls for booster shotsConcerns over the Omicron variant and waning vaccine-induced protection against the infection have highlighted the need for boosters to pro...
- Experts allay Covaxin concerns, effectiveness against Delta-driven Covid surge at 50% not badEfficacy is the degree to which a vaccine prevents disease, and possibly also transmission, under ideal and controlled conditions, while ef...
- No need for Covid booster doses in India at this stage, say expertsIn the US, a panel advising the Food and Drug Administration (FDA) has recommended boosters of Pfizer's Covid-19 vaccine for people 65 and ...
- Delta plus: New Covid variant identified, experts say no cause of concern for nowThough there is no indication yet of the severity of the disease due to the new variant, Delta plus is resistant to the monoclonal antibody...
- Booster effect even at six months, don't worry: Experts on Covishield dose gapThe government last week extended the gap between two doses of the Covishield COVID-19 vaccine to 12-16 weeks, up from the previous maximum...
- Don’t fret if second dose delayed, no need to restart vaccine schedule, say expertsIn the UK, recommended gap between two doses of Covishield is 12 weeks, while in Canada, authorities have opted for up to 16 weeks.
- No data on efficacy of India's COVID vaccines against South African, Brazilian variants: ScientistsOn Tuesday, the Health Ministry said four people were detected with the South Africa variant of SARS-CoV-2 and one tested positive for the ...
- 'Next-gen' COVID-19 vaccines may be needed to tackle emerging variants, say scientistsWork on vaccines will have to continue on parallel tracks - one to tackle the SARS-CoV-2 virus with first generation vaccines and the other...
- Vitamin D inexpensive, low-risk and can strengthen immune response to COVID-19: ExpertsStressing that Vitamin D is inexpensive and has negligible risk when compared to the considerable risk of COVID-19, global researchers on t...
- Six months since lockdown: Strides in testing, vaccine devt but COVID crisis far from over in India, say scientistsSix months on, India has the second highest number of cases in the world after the US with a tally of 57.32 lakh cases, 86,508 people testi...
- Presence of antibodies may not guarantee protection from COVID-19, say scientistsAs worries over India's COVID-19 spike mount - the country added 90,062 cases on Monday to take its tally past the 42-lakh mark - scientist...
- Scientists sceptical about Russia's Covid vaccine, cite lack of evidence for efficacyWhile the country hopes to start mass-producing the vaccine by October and plans to offer the first doses to essential workers, many in the...
- Too soon to say whether recovered COVID patients lose immunity with time, say scientistsSome special cells of the immune system may still offer protection against the disease, the scientists said as questions swirl on whether p...
Load More
